- Home
- RPRX vs DECK Comparison
RPRX vs DECK Comparison
Compare RPRX & DECK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RPRX | DECK |
|---|---|---|
| Founded | 1996 | 1973 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Shoe Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.2B | 12.4B |
| IPO Year | 2020 | 1993 |
Fundamental Metrics
Financial Performance| Metric | RPRX | DECK |
|---|---|---|
| Price | $39.70 | $99.39 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 21 |
| Target Price | $46.00 | ★ $121.63 |
| AVG Volume (30 Days) | ★ 4.3M | 3.5M |
| Earning Date | 11-05-2025 | 10-23-2025 |
| Dividend Yield | ★ 2.21% | N/A |
| EPS Growth | N/A | ★ 18.83 |
| EPS | 1.75 | ★ 6.75 |
| Revenue | $2,349,844,000.00 | ★ $5,244,323,000.00 |
| Revenue This Year | $37.13 | $9.84 |
| Revenue Next Year | $1.48 | $7.36 |
| P/E Ratio | $22.68 | ★ $14.77 |
| Revenue Growth | 3.70 | ★ 12.62 |
| 52 Week Low | $24.05 | $78.91 |
| 52 Week High | $41.24 | $223.98 |
Technical Indicators
Market Signals| Indicator | RPRX | DECK |
|---|---|---|
| Relative Strength Index (RSI) | 57.50 | 67.87 |
| Support Level | $39.24 | $81.40 |
| Resistance Level | $40.50 | $86.09 |
| Average True Range (ATR) | 0.91 | 3.00 |
| MACD | -0.08 | 2.31 |
| Stochastic Oscillator | 76.02 | 99.97 |
Price Performance
Historical ComparisonAbout RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About DECK Deckers Outdoor Corporation
Founded in 1973, California-based Deckers designs and sells casual and performance footwear, apparel, and accessories. In fiscal 2025, Ugg and Hoka accounted for 51% and 45% of total sales, respectively. The firm also markets niche brands Teva and Ahnu. Deckers produces most of its sales through wholesale partnerships but also operates e-commerce in more than 50 countries and has nearly 200 company-operated stores. It generated 64% of its fiscal 2025 sales in the United States.